Gloria Reeves

Affiliations: 
University of Maryland School of Medicine, Baltimore, MD, United States 
Google:
"Gloria Reeves"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

dosReis S, Saini J, Hong K, et al. (2022) Trends in antipsychotic use for youth with attention-deficit/hyperactivity disorder and disruptive behavior disorders. Pharmacoepidemiology and Drug Safety
Akouri-Shan L, Schiffman J, Millman ZB, et al. (2021) Relations Among Anhedonia, Reinforcement Learning, and Global Functioning in Help-seeking Youth. Schizophrenia Bulletin
Millman ZB, Gallagher K, Demro C, et al. (2019) Evidence of reward system dysfunction in youth at clinical high-risk for psychosis from two event-related fMRI paradigms. Schizophrenia Research
Ross M, Nguyen V, Bridges JFP, et al. (2018) Caregivers' Priorities and Observed Outcomes of Attention-Deficit Hyperactivity Disorder Medication for Their Children. Journal of Developmental and Behavioral Pediatrics : Jdbp. 39: 93-100
Waltz J, Demro C, Millman Z, et al. (2018) 26.3 SALIENCE SIGNALING AND THE EMERGENCE OF PSYCHOPATHOLOGY IN YOUTH AT CLINICAL HIGH RISK FOR PSYCHOTIC ILLNESS Schizophrenia Bulletin. 44: S43-S43
Demro C, Rowland L, Wijtenburg SA, et al. (2017) Glutamatergic metabolites among adolescents at risk for psychosis. Psychiatry Research. 257: 179-185
dosReis S, Park A, Ng X, et al. (2016) Caregiver Treatment Preferences for Children with a New Versus Existing Attention-Deficit/Hyperactivity Disorder Diagnosis. Journal of Child and Adolescent Psychopharmacology
Ng X, Bridges JF, Ross MM, et al. (2016) A Latent Class Analysis to Identify Variation in Caregivers' Preferences for their Child's Attention-Deficit/Hyperactivity Disorder Treatment: Do Stated Preferences Match Current Treatment? The Patient
Ereshefsky S, Thompson E, Demro C, et al. (2016) Social and role functioning in help-seeking youth with clinical-high risk, ADHD comorbidity, and history of psychostimulant exposure F1000research. 5
Ross M, Kim H, Bridges J, et al. (2016) Initiating Medication To Treat Pediatric Attention-Deficit/Hyperactivity Disorder: A Best-Worst Scaling To Compare Caregivers’ And Clinicians’ Preferences Value in Health. 19
See more...